Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Gains from Investment Securities (2020 - 2025)

Maravai Lifesciences Holdings has reported Gains from Investment Securities over the past 6 years, most recently at -$782000.0 for Q4 2025.

  • Quarterly results put Gains from Investment Securities at -$782000.0 for Q4 2025, down 167.65% from a year ago — trailing twelve months through Dec 2025 was -$206000.0 (down 930.0% YoY), and the annual figure for FY2025 was -$212000.0, down 111.78%.
  • Gains from Investment Securities for Q4 2025 was -$782000.0 at Maravai Lifesciences Holdings, down from $200000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for MRVI hit a ceiling of $7.1 million in Q3 2022 and a floor of -$11.2 million in Q4 2022.
  • Median Gains from Investment Securities over the past 5 years was -$19000.0 (2024), compared with a mean of -$1.4 million.
  • Biggest five-year swings in Gains from Investment Securities: soared 889.47% in 2021 and later plummeted 2700.0% in 2022.
  • Maravai Lifesciences Holdings' Gains from Investment Securities stood at $300000.0 in 2021, then crashed by 3846.33% to -$11.2 million in 2022, then surged by 71.73% to -$3.2 million in 2023, then skyrocketed by 136.39% to $1.2 million in 2024, then crashed by 167.65% to -$782000.0 in 2025.
  • The last three reported values for Gains from Investment Securities were -$782000.0 (Q4 2025), $200000.0 (Q3 2025), and $140000.0 (Q2 2025) per Business Quant data.